Results 221 to 230 of about 172,683 (289)

Correction: Transition From a Paper Diary to an Electronic Diary by Parents of Preschool Children With Food Allergies: Pilot Study. [PDF]

JMIR Form Res
Kato Y.
europepmc   +1 more source

"One of the Hardest Things I Have to Do in the Clinic": A Survey of Veterinary Team Members' Knowledge, Attitudes, and Practices Regarding Nail Clipping. [PDF]

Vet Sci
Chen A, Hall E, Bennington LN, McGowan C, Quain A.   +4 more
europepmc   +1 more source

THE EFFECT OF “OP ART” MOVEMENT TO CLOTHING FAS

, 2019
Fatma Yelda GEZİCİOĞLU, Özlem Uslu
openalex   +2 more sources

Exercise serum promotes DNA damage repair and remodels gene expression in colon cancer cells

International Journal of Cancer, EarlyView.
What's New? Exercise releases bioactive molecules into the bloodstream that can directly slow cancer cell growth. In colon cancer, this may help limit disease progression. Here, using colon cancer cells, the authors investigated the effects of exercise‐conditioned human serum on DNA repair mechanisms. Notably, acute exercise in humans elicited systemic
Samuel T. Orange, Emily Dodd, Sharanya Nath, Hannah Bowden, Alastair R. Jordan, Hannah Tweddle, Ann Hedley, Ifeoma Chukwuma, Ian Hickson, Sweta Sharma Saha   +9 more
wiley   +1 more source

Association of omega-3 fatty acids with improved prognosis after myocardial infarction: the role of red cell distribution width-an EHR study. [PDF]

Eur J Med Res
Wang Y, Dong C, Feng Y, Zhang W, Yuan M, Ma Y, Liu C, Gao D.   +7 more
europepmc   +1 more source

Case Report: FAS spontaneous mutation in a familial hemophagocytic lymphohistiocytosis patient with a complex heterozygous mutation in PRF1 [PDF]

Wenwen Ding, Danni Li, Qi Yu, Yuping Wang, Lei Zhang   +4 more
openalex   +1 more source

Real‐world progression‐free survival and overall survival in patients with HR+/HER2− advanced breast cancer treated in first‐line with ribociclib, endocrine monotherapy or chemotherapy: Results from the observational RIBANNA study

International Journal of Cancer, EarlyView.
What's New? The CDK4/6 inhibitor ribociclib in combination with an endocrine‐based therapy has demonstrated significant progression‐free and overall survival benefits in patients with advanced/metastatic HR+/HER2‐ breast cancer in the pivotal MONALEESA trials.
Peter A. Fasching, Cosima Brucker, Thomas Decker, Anne Engel, Thomas Göhler, Christian Jackisch, Jan Janssen, Andreas Köhler, Kerstin Lüdtke‐Heckenkamp, Diana Lüftner, Frederik Marmé, Marion van Mackelenbergh, Beate Rautenberg, Marcus Schmidt, Rudolf Weide, Pauline Wimberger, Elena Kisseleff, Christina Pfister, Claudia Quiering, Christian Roos, Achim Wöckel   +20 more
wiley   +1 more source

Fatty acids alter to the toxicity of islet amyloid polypeptide aggregates in a length and saturation dependent manner. [PDF]

iScience
Sitton J, Pickett D, Hung A, Elsaigh R, Kurouski D.   +4 more
europepmc   +1 more source

Targeting Microbiome Metabolites: Reshaping Immunotherapy and Clinical Management Strategies for Colorectal Cancer

iMetaMed, EarlyView.
The occurrence and progression of colorectal cancer are intricately linked to metabolites produced by the gut microbiota. Metabolites generated by pathogenic microbial communities can promote colorectal cancer development by reshaping the immune microenvironment.
Xinrui Yang, Ke Zhang, Lijie Xia, Jinyao Li   +3 more
wiley   +1 more source

Mechanistic and therapeutic dimensions of DcR3-mediated immunomodulation in sepsis. [PDF]

Front Immunol
Abbas B, Lin X, Xu C, Chen Q, Su J.
europepmc   +1 more source